PlainPharmaWatch

CMS Open Payments · Program Year 2024

Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals, Inc. reported $1,190,343.46 in payments to 8,453 physicians and teaching hospitals across 8,463 transactions.

See the rankings → How this is sourced
$1.2M
Total payments
8,463
Transactions
8,453
Recipients
+$492.6K
General Payments vs PY2023

Catalyst Pharmaceuticals, Inc. reported $1,190,343.46 in payments to 8,453 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #582 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $140.82 per recipient across 6 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Catalyst Pharmaceuticals, Inc. pairs above-median payment volume with an unusually diversified payment pattern across a wide recipient base.

#582
of 1,925 companies
0.0%
of all US industry payments
0.1%
paid to its single top recipient
6
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

Catalyst Pharmaceuticals, Inc.'s CMS-reported General Payments increased by $492.6K (+86.0%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: CATALYST PHARMACEUTICALS, INC.PY2023: CATALYST PHARMACEUTICALS, INC.PY2024: CATALYST PHARMACEUTICALS, INC.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$573.0KPY2024$1.1M
PY2023
$573,008.90
PY2024
$1,065,562.46

How Catalyst Pharmaceuticals, Inc. ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Catalyst Pharmaceuticals, Inc.'s total vs. every reporting company

CMS Open Payments, Program Year 2024

$1,190,343 Top 30% higher than 70% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). Below this entry. $752,621–$2,337,813: 263 reporting companies (14%). This entry sits in this band. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Catalyst Pharmaceuticals, Inc.

$1,190,343.46: that is what Catalyst Pharmaceuticals, Inc. reported in payments to 8,453 physicians and teaching hospitals during Program Year 2024, spread across 8,463 transactions ($140.65 per transaction, $140.82 per recipient). The company sits at rank #582 of 1,925, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

242 transactions worth $614.8K make "Honoraria" the top general-payment category in the 6-category breakdown below, 51.6% of the reported total (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

"Honoraria" leads Catalyst Pharmaceuticals, Inc.'s 6-category general-payment breakdown at $614.8K, 51.6% of the reported total.

How Catalyst Pharmaceuticals, Inc. divides its payments

Ranked by total dollars reported per category

1. Honoraria$614.8K2. Food and Beverage$194.1K3. Travel and Lodging$104.0K4. Consulting Fee$100.4K5. Grant$36.3K6. Education$16.1K
Payment Type Amount Transactions
Honoraria $614.8K 242
Food and Beverage $194.1K 6,865
Travel and Lodging $104.0K 325
Consulting Fee $100.4K 36
Grant $36.3K 11
Education $16.1K 974

Recipient Concentration in General Payments

The five largest recipient relationships account for $244,239.55 (22.9%) of $1,065,562.46 in this company's General Payments records across 2,946 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Catalyst Pharmaceuticals, Inc.

The five named recipients with the highest reported General Payments from this company

Selim Ramin Benbadis$79.9KAtiya S. Khan$56.5KSteve S Chung$38.9KMatthew C. Holtzman$38.7KJesus Eric Pina Garza$30.2K
  1. 1

    Selim Ramin Benbadis

    $79,898.41 across 72 reported transactions

  2. 2

    Atiya S. Khan

    $56,525.79 across 62 reported transactions

  3. 3

    Steve S Chung

    $38,871.62 across 33 reported transactions

  4. 4

    Matthew C. Holtzman

    $38,710.28 across 47 reported transactions

  5. 5

    Jesus Eric Pina Garza

    $30,233.45 across 23 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $140.65. Average per recipient: $140.82.

Total Amount

$1,190,343.46

Avg per Transaction

$140.65

Avg per Recipient

$140.82

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Catalyst Pharmaceuticals, Inc. Share

0.0%

#582 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Catalyst Pharmaceuticals, Inc.

GenBioPro, Inc.

$1.2M 15 recipients

The North Carolina Mutual Wholesale Drug Company Inc

$1.2M 0 recipients

DiaSorin Inc.

$1.2M 37 recipients

BTG International, Inc.

$1.2M 757 recipients

Organ Recovery Systems, Inc.

$1.2M 84 recipients

Pulmonx Corporation

$1.2M 4,502 recipients

Frequently Asked Questions

How much did Catalyst Pharmaceuticals, Inc. pay to physicians and hospitals in 2024? ▾
In Program Year 2024, CMS Open Payments recorded $1,190,343.46 from Catalyst Pharmaceuticals, Inc. to physicians and hospitals across 8,463 transactions - 0.0% of all industry payments reported that year.
How many physicians received payments from Catalyst Pharmaceuticals, Inc.? ▾
8,453 physicians and teaching hospitals received payments from Catalyst Pharmaceuticals, Inc. in 2024, averaging $140.82 per recipient.
What types of payments did Catalyst Pharmaceuticals, Inc. make? ▾
6 categories of general payment make up Catalyst Pharmaceuticals, Inc.'s reported activity, including consulting, meals, travel, and similar types. The largest general-payment category was "Honoraria" at $614.8K, representing 51.6% of the company's reported total.
How does Catalyst Pharmaceuticals, Inc. rank among pharmaceutical companies? ▾
By total payment amount, Catalyst Pharmaceuticals, Inc. sits at #582 of 1,925 companies in the CMS Open Payments database for 2024.
What is the average payment size from Catalyst Pharmaceuticals, Inc.? ▾
Catalyst Pharmaceuticals, Inc.'s 8,463 transactions to 8,453 recipients in 2024 averaged $140.65 per transaction.
Where does the payment data for Catalyst Pharmaceuticals, Inc. come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Catalyst Pharmaceuticals, Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.